Empiric use of anticoagulant and fibrinolytic agents in surgery.
D000208:Acute Disease; D000925:Anticoagulants / Q000627:therapeutic use*; D001780:Blood Coagulation Tests; D006348:Cardiac Surgical Procedures; D001026:Coronary Artery Bypass; D003911:Dextrans / Q000627:therapeutic use; D005260:Female; D005343:Fibrinolytic Agents / Q000494:pharmacology; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007263:Infusions, Parenteral; D007279:Injections, Subcutaneous; D011183:Postoperative Complications / Q000517:prevention & control*; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy; D011516:Prothrombin / Q000037:antagonists & inhibitors; D011517:Prothrombin Time; D011655:Pulmonary Embolism / Q000188:drug therapy / Q000517:prevention & control; D013514:Surgical Procedures, Operative; D013923:Thromboembolism / Q000517:prevention & control*; D013924:Thrombophlebitis / Q000188:drug therapy; D013927:Thrombosis / Q000517:prevention & control; D014656:Vascular Surgical Procedures; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use
D000925:Anticoagulants; D003911:Dextrans; D005343:Fibrinolytic Agents; D014859:Warfarin; D011516:Prothrombin; D006493:Heparin